Low-Cost Syringe Technology May Enable Subcutaneous Injection of Viscous Formulations

Goodwin
Contact

GoodwinIn late August, MIT announced that a group of MIT researchers led by Kripa Varanasi published a paper describing a low-cost technology for administering biological drug formulations otherwise too viscous to be injected using conventional medical syringes.  The system utilizes a syringe having an inner barrel containing viscous drug fluid and an outer barrel containing a thin coating of lubricant capable of reducing injection force by up to seven times.  In the announcement, Dr. Varanasi explained that the improvement may enable patients to self-administer drugs that would ordinarily require a hospital visit and allow drug developers to explore high-viscosity treatments that were previously inaccessible due to injectability barriers.  For example, he noted that the technology could play an important role during the current pandemic by enabling immunocompromised patients to subcutaneously self-administer medication at home.  More broadly, Varanasi believes that “[s]elf-administration of drugs or vaccines can help democratize access to health care.”

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Goodwin | Attorney Advertising

Written by:

Goodwin
Contact
more
less

Goodwin on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.